Hetlioz
RxNorm concept 1491619, brand name (bn).
- RxCUI
- 1491619
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1491619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- tasimelteon 20 MG [Hetlioz] (SBDC, ingredient of)
- tasimelteon Oral Capsule [Hetlioz] (SBDF, ingredient of)
- Hetlioz Oral Product (SBDG, ingredient of)
- Hetlioz Pill (SBDG, ingredient of)
- tasimelteon 20 MG Oral Capsule [Hetlioz] (SBD, ingredient of)
- tasimelteon 4 MG/ML [Hetlioz] (SBDC, ingredient of)
- tasimelteon Oral Suspension [Hetlioz] (SBDF, ingredient of)
- Hetlioz Oral Liquid Product (SBDG, ingredient of)
- tasimelteon 4 MG/ML Oral Suspension [Hetlioz] (SBD, ingredient of)
- tasimelteon (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1491619 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1491619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1491619. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.